Education
About Us
Working with TipRanks
Follow Us
Natera (NTRA)
NASDAQ:NTRA
Ctdna-Guided Treatment Strategy
Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (For Er-Positive Requirement)
Phase II
Not Yet Recruiting
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sep 24, 2025
―
Atezolizumab, Signatera
Muscle-Invasive Bladder Cancer
Phase III
Active Not Recruiting
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy
Dec 01, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Natera (NTRA) have in its pipeline
NTRA is currently developing the following drugs: Ctdna-Guided Treatment Strategy, Atezolizumab, Signatera. These drug candidates are in various stages of clinical development as the company works toward FDA approval.